Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques
暂无分享,去创建一个
[1] O. De Wever,et al. Fibroblast activation protein‐α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations , 2016, Molecular oncology.
[2] Dehai Che,et al. Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis , 2015, PloS one.
[3] S. Ha,et al. The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma , 2014, PloS one.
[4] A. Sikorski,et al. Upregulated expression and activation of membrane‑associated proteases in esophageal squamous cell carcinoma. , 2014, Oncology reports.
[5] J. Lai,et al. Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs , 2013, FEBS open bio.
[6] Timothy Marsh,et al. Fibroblasts as architects of cancer pathogenesis. , 2013, Biochimica et biophysica acta.
[7] James O. Jones,et al. Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia , 2013, The Journal of experimental medicine.
[8] Kunwei Shen,et al. Stromal cells in tumor microenvironment and breast cancer , 2012, Cancer and Metastasis Reviews.
[9] J. Isaacs,et al. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. , 2012, Journal of the National Cancer Institute.
[10] J. Isaacs,et al. Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy , 2012, Molecular Cancer Therapeutics.
[11] Y. Huang,et al. Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions , 2011, Clinical & Experimental Metastasis.
[12] M. Gorrell,et al. Neuropeptide Y, B‐type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein‐α , 2011, The FEBS journal.
[13] S. Hoerstrup,et al. Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata , 2011, European heart journal.
[14] Rafael Sirera,et al. The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[15] E. Montgomery,et al. Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers , 2009, Cancer biology & therapy.
[16] J. Nesland,et al. Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[17] B. O'connor,et al. Seprase: an overview of an important matrix serine protease. , 2008, Biochimica et biophysica acta.
[18] Silke von Ahlfen,et al. Determinants of RNA Quality from FFPE Samples , 2007, PloS one.
[19] P. Bechi,et al. Real-time PCR Analysis of RNA Extracted From Formalin-fixed and Paraffin-embeded Tissues: Effects of the Fixation on Outcome Reliability , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[20] Yuling Luo,et al. Direct quantification of gene expression in homogenates of formalin-fixed, paraffin-embedded tissues. , 2006, BioTechniques.
[21] E. Puré,et al. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. , 2006, Human pathology.
[22] G. McCaughan,et al. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX‐2 human stellate cell line , 2005, Hepatology.
[23] Thomas Kelly,et al. Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[24] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[25] A. Houghton,et al. FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor , 2004, Oncogene.
[26] U. Müller-Ladner,et al. Microarrays demystified. , 2004, Environmental health perspectives.
[27] Thomas Kelly,et al. Seprase complexes in cellular invasiveness , 2003, Cancer and Metastasis Reviews.
[28] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[29] J. Park,et al. Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts* , 1999, The Journal of Biological Chemistry.
[30] C. Abbott,et al. Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis , 1999, Hepatology.
[31] K. Umeki,et al. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma , 1995, International journal of cancer.
[32] W. T. Chen,et al. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. , 1994, Cancer research.
[33] Thomas Kelly,et al. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. , 2012, International review of cell and molecular biology.
[34] P. Cirri,et al. Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.
[35] A. Houghton,et al. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. , 2004, Oncogene.
[36] S. Iwata,et al. Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. , 2002, Cellular immunology.